(Q37993823)

26 August 2017

Mammalian target of rapamycin and the kidney. I. The signaling pathway (English)

1 reference

26 August 2017

1 reference

Wilfred Lieberthal

1

1 reference

PubMed ID

22419691

26 August 2017

Jerrold S Levine

series ordinal

2

1 reference

26 August 2017

14 March 2012

1 reference

American Journal of Physiology - Renal Physiology

26 August 2017

1 reference

26 August 2017

303

1 reference

26 August 2017

1

1 reference

26 August 2017

F1-10

1 reference

New insights into mTOR signaling: mTORC2 and beyond

26 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

HEAT repeats in the Huntington's disease protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Recent advances in the regulation of the TOR pathway by insulin and nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Key factors in mTOR regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Rapamycin and mTOR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Advances in protein kinase B signalling: AKTion on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Epithelial sodium channel regulated by aldosterone-induced protein sgk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

An amino acid shuffle activates mTORC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TOR complex 2: a signaling pathway of its own.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR and cancer: many loops in one pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The coordinate regulation of the p53 and mTOR pathways in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The pharmacology of mTOR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of eIF-4E BP1 phosphorylation by mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Signal transduction: How cells sense energy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Restraining PI3K: mTOR signalling goes back to the membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation mechanisms and signaling pathways of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The TSC1-TSC2 complex is required for proper activation of mTOR complex 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TOR regulation of AGC kinases in yeast and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of TORC1 by Rag GTPases in nutrient response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Autophagy: from phenomenology to molecular understanding in less than a decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

HEAT repeats mediate plasma membrane localization of Tor2p in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR signaling at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR complex-2 activates ENaC by phosphorylating SGK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Molecular mechanisms of mTOR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

RalA functions as an indispensable signal mediator for the nutrient-sensing system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Targeting phosphoinositide 3-kinase: moving towards therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Autophagy in mammalian development and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Spatial coupling of mTOR and autophagy augments secretory phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Bidirectional transport of amino acids regulates mTOR and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

AMPK is a direct adenylate charge-regulated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Identification of Protor as a novel Rictor-binding component of mTOR complex-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Rheb promotes cell growth as a component of the insulin/TOR signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of PTEN transcription by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Rheb is an essential regulator of S6K in controlling cell growth in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR signaling: PLD takes center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Implications of autophagy for glomerular aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Impaired renal Na(+) retention in the sgk1-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Molecular organization of target of rapamycin complex 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Eaten alive: a history of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00014.2012

10.1152/AJPRENAL.00014.2012

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22419691